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activities. The Reports had a very short life span, however, because there
were actually many issues other than communication, and the decision
was soon made to publish the Journal of the American Academy of
Dermatology. Fortunately, my dire predictions for the effects of this
decision on the JID and the JAAD proved to be incorrect, since both
journals are doing extremely well in 1989. It just proves that you can’t be
right all of the time.
In contrast, my predictions were correct when in December, 1973, I
began to communicate with the leaders of what was then a small, young
investigative group in Europe, the ESDR. After the first few years of their
existence, they also had to face the question of a journal. They basically
had two choices: begin a new publication or affiliate with a journal
already in existence, either in Europe or in the United States. The JID was
attracting a significant number of exciting papers from Europe, so the
members of the Editorial Board and I were very concerned that a new
European journal in the area of skin research could lead to the loss of
important contributions for us.
The discussions on both sides of the Atlantic were intense, focused and,
to me, extremely exciting. I met a wonderful group of first-rate dermatologic
scientists and by January, 1976, our efforts were successful. The JID appeared
for the first time that month carrying the logos of both the ESDR and the SID.
Since that time, the relationship between the two societies has grown even
stronger, and the Journal has thrived—not as two separate publications
under one cover, but as a truly integrated publication representing academic
investigative dermatology on both sides of the Atlantic.
As I have taken this ‘‘backward look,’’ the agreement between the
ESDR and the SID is what stands out as most important. It eclipses our
problems with the publisher, the difficult editorial decisions which had to
be made, the concerns about meeting deadlines, and even the major
worries about the thin issues of 1972. The only thing that matches the
SID/ESDR relationship in importance is the overall appreciation I now
have of those exciting, productive years between 1972 and 1977. They
were of central importance in my professional life, and I shall always
remain grateful for the opportunity which that committee gave to me.
Coming of Age
Ruth K. Freinkel, M.D. (1977–1982)
The entire Journal of Investigative Dermatology arrived at my office at
Northwestern Medical School on a hot day in June of 1977. It came in the
form of a large number of cardboard boxes containing all of its 68
unbound volumes, a filing cabinet filled with manuscripts, a thick folder
of reviewer names, and a pica ruler for measuring printed lines. My
tenure as Editor of The Journal of Investigative Dermatology had begun,
and my quiet, comfortable, academic life in a small department had
ended for the next five years.
Surveying the disorder, I had very mixed emotions—enthusiasm and
excitement for the task I had undertaken, confidence that I had the
support of a superb editorial board, trepidation about whether I was
really qualified for the job, and a sense of wonderment that all of these
boxes and filing drawers contained the Journal which had been such an
important part of my professional life for nearly 20 years.
I recalled the thrill of seeing my first dermatological paper appear in the
JID in 1960y the smug feeling of having ‘‘arrived’’ the first time Naomi
Kanof asked me to review an articley endless discussions with my friend
and mentor, Irvin Blank, about how we would do it bettery and much
later, my years on the editorial board with Irwin Freedberg during a time
when both the Journal and the scientific base of dermatology were growing
rapidly. And I wondered whether I really could do IT as well, let alone
better than my distinguished predecessors.
I did not know then that the next five years would be one long
deadline, with piles of manuscripts lurking accusingly in the filing
cabinet and on my kitchen table, with hundreds of phone calls from
anxious or angry authors (happy ones never called) or to laggard
reviewers. And I could only guess at the satisfaction of seeing each
pristine issue (sometimes tempered with irritation when it was late or
when it contained some gigantic booboo such as mislabeled figures).
I had not yet experienced the sinking feeling in my stomach when two
reviewers came to exactly opposite recommendations and the third sat
squarely on the fence. I had not yet experienced the excitement of
reading a brilliant paper that solved a major question. I had not yet felt
sad when I had to reject a bad paper from an aspiring young investigator
or happy when an author thanked me for helping to improve a mediocre
manuscript.
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Five years later, when I packed up those same filing cabinets and
boxes and sent the list of reviewers and the pica ruler to Howard Baden,
it was with a sense of loss and satisfaction not unlike that experienced
when your oldest child goes off to college. It had been my baby for five
years, but only on loan, and now it was under someone else’s
stewardship.
Ten years later, I can look at the years of my stewardship with some
perspective and only a smidgen of nostalgia.
First, the years between 1977 and 1982 represented a period of
exponential growth in dermatological research that had begun in the
early 1970 s sparked by real, if modest, increases in funding opportu-
nities, and fueled by an influx of talented young investigators committed
to building the scientific structure of dermatology. The Journal’s fortunes
were inextricably linked to that growth, as reflected in the papers
submitted for publication. In 1982, submission of unsolicited manuscripts
had increased by 55% to 375. To accommodate this growth, we had
increased both page numbers and page size (the latter decision was
among our most controversial, since it required changes in thousands of
book shelves) and had been able to increase the number of published,
refereed papers by 45%.
Although we were delighted at this growth, it produced some thorny
issues which gave me a permanent headache. Money was a constant
problem to be faced not only by me, but also by the Board of Directors,
since the growth of the science was never paralleled by growth in the
subscription list which increased only 10% in those five years. We dealt
with the financial woes by gingerly applied increases in subscription
rates, by instituting page charges, and by unremitting bargaining with our
long-time publisher, Williams and Wilkins. We searched endlessly for
small economies, such as buying our own stamps instead of using the
institutional franking machine.
Space was a continuing major problem—the available pages did not
keep pace with available papers and the specter of an unacceptably long
publication lag, and a high rejection rate hung over our heads like a
black cloud. To economize on space, we eliminated the practice of
starting each article on a new page. But, to preserve the sanity of the
readers and my own reverence for the English language, we resisted the
use of abbreviations in the abstracts.
It was also a time of increasing specialization in research endeavors.
The era had passed when all of the knowledge about the biology
of skin could be encompassed in a single book of 741 pages, such as
Rothmans’s classic text, or new frontiers covered in a single journal.
The growth of dermatopathology had already produced its own journal,
and immunodermatology was becoming a major sub-specialty. For the
first time, the JID was competing with other research journals for
the best and most exciting work in a variety of discipline-
oriented publications including those emanating from departments of
dermatology. If it was to keep its preeminence, it needed to find a
way to attract those papers. Various approaches were considered,
and one that was adopted was the Rapid Communication section to
allow a relatively quicker publication of important new discoveries.
My desperation, at one time, led me to attempt to blackmail the
distinguished members of the editorial board into submitting their work
by exposing their failure to publish in the JID at an editorial board
meeting.
The contents of the Journal reflected the changing nature of research
in dermatology: papers in the area of immunology increased to more than
25% of all papers published, while papers dealing with psoriasis,
photobiology, and pigmentation remained at a stable 23%, and acne
research declined to less than 4%. Ultrastructural studies increased as the
JID was one of a handful of journals recognized for the excellence of its
reproductions. Molecular biology and modern cell biology were just
beginning to make inroads in our field and our journal. These were
exciting changes and reflected the growing sophistication of dermatolo-
gical research, but for the editor, they posed a challenge. They required a
new level of expertise among reviewers and new judgments in setting
priorities for publication.
They also increased the information gap between the Journal and its
readers. Most specifically, the residents and more clinically oriented
readers were feeling that the JID had less to offer them because of the
increasingly unfamiliar nature of basic research in its pages. We attacked
this problem with review articles and publications of special symposia,
but never made much headway. My successor provided the first
innovative solution to this gap by the enormously successful introduction
of Gina Kolata’s monthly column which explained the significance of
certain new observations.
I was keenly aware of the vital importance of making the Journal
available, as well as relevant, to residents who represent the future of the
specialty. This involved maintaining subsidization of resident subscrip-
tions, and I was eternally grateful to the Westwood Corporation which
continued its unstinting support during my tenure. I was also aware that
clinical research needed to be represented amply in the Journal if it was
to remain a vital force in the dermatological community. On this score,
the JID faced stiff competition with the existing clinical journals and the
infant Blue Journal, as well as internal competition with basic research
submitted for its pages. This problem has not yet been solved and grows
worse as fundamental research in all clinical fields moves farther from
the clinic and the hands of clinically oriented researchers.
One of the great paradoxes, which saw its beginnings during my
tenure as Editor, was the amazing increase in work submitted while
funding of research in this country was rushing into a headlong decline. I
had worried that we would not be able to fill our pages. Instead, I found
myself agonizing over piles of manuscripts for which we lacked space
and facing the disgrace of exceeding our contractual agreements for the
number of pages per year. The reason for this apparent paradox was
never entirely clear. To a great extent, it reflected the coming of age of
research departments fully staffed with hard-working faculty and fellows.
However, it also reflected the keen competition for research funds and
the increasing and lamentable tendency to publish many small and
fragmented pieces of work, so as to boost apparent productivity. Thus,
papers became shorter and less complete during those years, and
investigators were no longer content to present an entire year’s work in
one or two publications. For the editors and reviewers, this presented a
new and difficult problem in making judgments as to what constituted a
piece of work.
One of the major preoccupations of the JID during my years was the
internationalization of the Journal. The amalgamation of the European
Society for Dermatological Research and the Society of Investigative
Dermatology in sponsorship of the JID had been accomplished by my
predecessor, and it was left to me to make it a happy and fruitful union.
This challenge required delicacy and diplomacy.
For the Europeans, the JID was a new outlet that was welcomed
by most, but viewed by many with some suspicion. Would the editorial
board, then dominated by Americans, deal fairly with work from Europe?
Would work published in the JID be sufficiently disseminated in Europe?
How could the ESDR find its proper voice in the policy decisions
affecting the Journal? In retrospect, this was the most challenging aspect
of my editorship. Achieving a successful marriage of the two Societies
and the adoption of their now joint progeny, the JID, required more than
a formal wedding ceremony. Like any other marriage, it required
establishing relationships between the in-laws, finding ways to deal with
little and big family disagreements, and trying to continually assure both
sides of the family that they shared equally in the affections and
upbringing of the offspring.
To this end we worked hard to maintain and increase the publications
from the ESDR which by 1982 had reached 27% of the papers published.
More importantly, we made strenuous efforts to involve the European
scientists in the reviewing process, and by 1982, had increased European
reviewers by 64%. Most important of all, by the end of my term,
acceptance rates were nearly equal on both sides of the Atlantic Ocean.
When the joint ESDR-SID committee met to select my successor, there
was a congenial family atmosphere that suggested that I had, in fact,
succeeded in forging a strong and lasting union.
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It was also clear at that time that internationalization had just begun.
Submissions from Japan had constituted only about 5% of the total in
1977, but more than doubled by 1982. Moreover, the quality of Japanese
papers was improving significantly, as reflected in increasing acceptance
rates. Now, ten years later, this trend can be seen to have presaged the
enormous involvement of Japanese scientists in investigative dermato-
logy, as reflected in the pages of JID.
In preparing this retrospective, I have pondered on my place in
the history of the Journal. The Editor of a major scientific journal has a
unique opportunity and an awesome responsibility which I defined in my
first Editorial ( J Invest Dermatol 69:193, 1977). The responsibility that I
perceived was to ‘‘enlist the partnership, critical input and contributions
of all segments of the community of investigators of the skin.’’ The
opportunity was to imprint my personal philosophy of excellence and
produce a journal which reflected the ‘‘broad mixture of biological
enquiries that is essential if research in dermatology is to be meaningfully
translated into help for the patient.’’
There were times during my years when these grand objectives seemed
impossibly hard and when the day-to-day tasks overwhelmed the broad
goals. On the whole, I trust that I steered the Journal on a straight course
during times of great change and faithfully discharged my responsibilities
as I saw them. The Journal I handed over to my successor was better than
the one I received, but only because the Science was better and more
mature. Some of my goals were achieved, in particular that of cementing
the international support of the Journal. Others were passed on to the next
Editor only partially fulfilled. Chief among these was the desire to make the
JID a journal reflecting the whole broad scientific base of dermatology.
But, in truth, this is a goal that cannot be fulfilled, but rather should be a
light on the path to the future; for the answer to each scientific question
brings new questions and new ways of answering them. I believe that,
during my years, the Journal encompassed the most relevant questions and
answers of the time. The challenge to its future is to continue successfully
on that path during the next 50 years. As one of its long line of foster
parents, I wish for it continued good fortune.
Prosperity and Growth
Howard P. Baden, M.D. (1982–1987)
Not long after assuming the editorship, I wondered whatever possessed
me to take the job. I was working night and day, weekends included, and
felt insecure about decisions because of severe limitations of space. Both
the SID and ESDR were concerned about the rising costs of running the
Journal, and I had all these terrific papers to publish, some of which I had
to reject for lack of room. The phone calls and letters I received during
the first years had me looking over my shoulder on dark streets.
The worst part of it was that the quality of science was increasing at
an ever-faster pace. Probably leading the pack was immunology, with the
T cell and Langerhans cells threatening to take over the office. I had to
learn the language: I’m OK, you’re OK. I was elated by the helpers and
depressed by the suppressors. In a more serious vain, I was seeing really
good stuff, and I began to lose my despair and enjoy the revolution of
which I was a participant. It was also easier when I learned if some
reviewers said good, it meant great, and the reverse held true for others. I
do feel that the authors were generally understanding but not happy, and
it became clear that something needed to be done.
The first priority was to try and find a less-expensive way of
publishing the Journal. Our old publishers, Williams and Wilkins, were
willing to make some concessions, but could not match the other
companies that we contacted. Unfortunately, the quest for a new
publisher who could perform the same quality job as Williams and
Wilkins was time-consuming and dragged out much longer than I had
hoped. Ultimately, we settled on Elsevier, a publisher we felt could
maintain the quality, but lower our costs. The decision was made, and
we were off and running. While we were at it, we did some revamping,
including changing colors. Pat Novak was instrumental in picking the
cover design and color. What is in-between the covers is the most
important factor, but presentation of material helps a great deal.
While on the subject of Pat, I should comment on how important her
contribution to the Journal really was. I would say that after her editing of
many papers, although the science was no different, the method of
presentation and organization of data led to a much-improved manu-
script. Readability is key, particularly with topics with which one might
not be so familiar, and she helped a great deal.
So now, with a new publisher under our belts, we went after more
pages. But by this time it was easy. Both societies recognized that
publishing good work was the most important consideration, and
somehow the money would be found. Page charges were started and,
although it was suggested by some it would be our downfall, it was
accepted with a minimum of complaint.
In order to ensure that the financial resources would be available to
allow the Journal to expand in proportion to its needs, the Board of the
Society undertook to raise an endowment for the Journal. Generation of
income from advertisements and charges to authors cannot be expected to
grow by a significant amount, and it is therefore essential that a new source
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